Whereas ovarian cancer is the deadliest of all gynecologic cancers; Whereas ovarian cancer is the fifth leading cause of cancer deaths among women in the United States; Whereas in 2017, approximately 22,440 new cases of ovarian cancer will be diagnosed, and 14,080 women will die of ovarian cancer in the United States; Whereas the mortality rate for ovarian cancer has not significantly decreased since the War on Cancer was declared more than 40 years ago; Whereas a quarter of women will die within one year of diagnosis with ovarian cancer and over half will die within five years; Whereas there is the mammogram to detect breast cancer and the Pap smear to detect cervical cancer, there is currently no reliable early detection test for ovarian cancer; Whereas the lack of an early detection test means that approximately 80 percent of cases of ovarian cancer are detected at an advanced stage; Whereas all women are at risk for ovarian cancer, and approximately 20 percent of women diagnosed with ovarian cancer have a hereditary disposition of ovarian cancer, which places them at even higher risk; Whereas scientists and physicians have uncovered changes in the BRCA genes that some women inherit from their parents, which may make them 30 times more likely to develop ovarian cancer; Whereas a woman’s family history has been found to play an important role in accurately assessing her risk of developing ovarian cancer and medical experts believe a woman’s family history should be taken into consideration during her annual Well Woman visit; Whereas many experts in health prevention now recommend genetic testing for young women with a family history of breast and ovarian cancer; Whereas women who know they are at high risk of breast and ovarian cancer may undertake prophylactic measures to help reduce their risk for developing these diseases; Whereas the Society of Gynecologic Oncology now recommends that all women diagnosed with ovarian cancer receive counseling and genetic testing